Psychiatry

Latest AI and machine learning research in psychiatry for healthcare professionals.

7,399 articles
Stay Ahead - Weekly Psychiatry research updates
Subscribe
Browse Categories
Showing 1181-1200 of 7,399 articles

Artificial intelligence for adaptive neuromodulation in drug-resistant epilepsy.

Drug-resistant epilepsy (DRE) affects nearly one third of people with epilepsy and is associated with substantial cognitive, psychiatric, and mortality burdens. For patients who are not candidates for resection or laser interstitial thermal therapy, neuromodulation therapies such as vagus nerve stimulation, deep brain stimulation, and responsive neurostimulation offer an important and established ...

Mar 31 2026 41914206

Perspective: Depression in Persons with Parkinson's Disease.

Depression is a prevalent and disabling syndrome characterized by sustained sadness and/or anhedonia, as well as cognitive and physical symptoms. In Parkinson's disease (PD), depression is both common and clinically challenging due to overlapping symptoms and complex etiologic interactions. Major depressive disorder occurs in approximately 17% of PD patients, while clinically significant depressiv...

Mar 31 2026 41916878
Closing the Gap in Autism Genetics: Population-Specific Variants and the Imperative for Global Inclusion.

Autism spectrum disorder (ASD) is a highly heritable neurodevelopmental condition with an exceptionally complex and heterogeneous genetic architecture...

Mar 30 2026 41921886
Disentangling race and ethnicity in predicting symptoms of depression among young adults: A machine learning approach.

PURPOSE: Research is needed to understand racial and ethnic differences in symptoms of depression. Unfortunately, most studies examine these differenc...

Mar 30 2026 41921600
Predicting depression treatment outcomes for cognitive behavioural therapy using machine learning: A systematic review and meta-analysis.

BACKGROUND: Cognitive behavioural therapy (CBT) is an empirically-supported treatment for depression, although some patients respond well and others d...

Mar 30 2026 41930537
Smartphone-based digital phenotyping for detection of high-risk depression and anxiety in Korean community settings.

BACKGROUND: Smartphones generate continuous behavioral signals such as mobility and activity patterns, offering scalable opportunities for monitoring ...

Mar 30 2026 41969787
Developing policy and regulation for the safer use of artificial intelligence technologies for mental health in Australia.

Artificial intelligence is emerging as a powerful tool for improving mental health research and care, offering opportunities for early intervention, p...

Mar 30 2026 41913339
Help-Seeking in the Age of AI: Cross-Sectional Survey of the Use and Perceptions of AI-Based Mental Health Support Among US Adults.

BACKGROUND: Anecdotal evidence suggests that an increasing number of people are turning to generative artificial intelligence (GenAI) tools or artific...

Mar 30 2026 41793726
Fluency without understanding: risks of large language models in mental healthcare.

We always treat fluent language as a marker of intelligence and trustworthiness, often independent of factual accuracy. Large language models (LLMs) e...

Mar 30 2026 41906223
Don't predict if you cannot interpret: investigating the clinical viability of facial movements for machine-learning assisted diagnostics of bipolar disorder.

BACKGROUND: Numerous studies have explored the possibility of developing automatic detection pipelines that can seamlessly diagnose patients with bipo...

Mar 30 2026 41906728
Preferences, tailoring, and self-tailoring in internet-delivered treatments: lessons learned.

INTRODUCTION: Internet-delivered psychological treatments have been developed and tested in many trials and are also implemented. AREAS COVERED: The a...

Mar 30 2026 41906773
Mass Media Narratives of Psychiatric Adverse Events Associated With Generative AI Chatbots: Rapid Scoping Review.

BACKGROUND: Generative artificial intelligence (AI) chatbots have rapidly entered public use, including in contexts involving emotional support and me...

Mar 30 2026 41911018
Examining the Use of Consumer Wearable Devices and Digital Tools for Stress Measurement in College Students: Scoping Review of Methods.

BACKGROUND: College-aged students face persistent academic and social stress that adversely affects their mental and physical health. Digital phenotyp...

Mar 30 2026 41911361
Impact of an Immersive AI Simulation on Nursing Student Attitudes Toward Mental Illness.

There is simultaneously a global shortage of mental health professionals and a rising demand for mental health services. Nurses provide the largest sh...

Mar 30 2026 41912252
Blood plasma proteomic biomarkers for forecasting transition to psychosis in an Asian cohort.

Plasma proteomic biomarkers hold significant promise for enhancing clinical assessments and improving early detection of psychosis conversion; however...

Mar 30 2026 41912485
Exploring White Matter Microstructural Abnormalities Using MRI in Women With Premenstrual Dysphoric Disorder via Brain Connectome.

BACKGROUND: The neurostructural underpinnings of premenstrual dysphoric disorder (PMDD), particularly integrated white matter and network alteration, ...

Mar 30 2026 41913094
Bridging the Scales via Personalized Cellular Modeling and Deep Phenotyping in Schizophrenia.

IMPORTANCE: While growing evidence implicates synaptic dysfunction as a key pathophysiological mechanism in cognitive impairments in schizophrenia (SC...

Mar 28 2026 41902754
Convolutional neural network for real‑time localization of ganglionated plexi from bipolar intracardiac electrograms.

BACKGROUND: Precise localization of ganglionated plexi (GP) is critical for effective cardioneuroablation, yet current mapping relies on labour‑intens...

Mar 28 2026 41903033
Comparative Mortality Risk of Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Alzheimer's Disease: A Real‑World Retrospective Cohort Study with Treatment Effect Heterogeneity Analysis.

BACKGROUND: Second-generation antipsychotics (SGAs) are frequently used off-label to manage behavioral symptoms in Alzheimer's disease (AD), despite o...

Mar 28 2026 41903051
Browse Categories